Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities

Bibliography

• MCELROY S, ALLISON D, BRAY G: Obesity and mental disorders. Taylor and Francis Group, New York, NY (2006).
   Google Scholar
• KESSLER RC, MCGONAGLE KA, ZHAO S et al.: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch. Gen. Psychiatry (1994) 1(51):8-19.
   Google Scholar
• AMERICAN DIABETES ASSOCIATION: Diagnosis and classification of diabetes mellitus. Diabetes Care (2004) (27 Suppl. 1):S5-S10.
   Google Scholar
• KECK PE, BUSE JB, DAGOGO-JACK S et al.: Metabolic disease and severe mental illness. Postgraduate Medicine Special Report. McGraw-Hill Companies, Inc. Minneapolis, MN (2003).
   Google Scholar
• MCINTYRE RS, KONARSKI JZ, MISENER VL et al.: Bipolar disorder and diabetes mellitus: epidemiology, etiology, and treatment implications. Ann. Clin. Psychiatry (2005) 2(17):83-93.
   Google Scholar
• ANDERSON RJ, FREEDLAND KE, CLOUSE RE et al.: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care (2001) 6(24):1069-1078.
   Google Scholar
• FAGIOLINI A, FRANK E, SCOTT JA et al.: Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar. Disord. (2005) 5(7):424-430.
   Google Scholar
• RASGON N, JARVIK L: Insulin resistance, affective disorders, and Alzheimer’s disease: review and hypothesis. J. Gerontol. A Biol. Sci. Med. Sci. (2004) 2(59):178-183.
   Google Scholar
• STOLK RP, BRETELER MM, OTT A et al.: Insulin and cognitive function in an elderly population. The Rotterdam Study. Diabetes Care (1997) 5(20):792-795.
   Google Scholar
• REGER MA, WATSON GS, FREY WH et al.: Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype. Neurobiol. Aging (2006) 27(3):451-458.
   PubMed Web of Science ®Google Scholar
• CRAFT S, PESKIND E, SCHWARTZ MW et al.: Cerebrospinal fluid and plasma insulin levels in Alzheimer’s disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology (1998) 1(50):164-168.
   Google Scholar
• MCINTYRE RS, KONARSKI JZ, YATHAM LN: Comorbidity in bipolar disorder: a framework for rational treatment selection. Hum. Psychopharmacol. (2004) 6(19):369-386.
   Google Scholar
• KELLER MB: Prevalence and impact of comorbid anxiety and bipolar disorder. J. Clin. Psychiatry (2006) 67 (Suppl. 1):5-7.
   Google Scholar
• LUSTMAN PJ, CLOUSE RE: Treatment of depression in diabetes: impact on mood and medical outcome. J. Psychosom. Res. (2002) 4(53):917-924.
   Google Scholar
• HORROBIN DF, BENNETT CN: Depression and bipolar disorder: relationships to impaired fatty acid and phospholipid metabolism and to diabetes, cardiovascular disease, immunological abnormalities, cancer, ageing and osteoporosis. Possible candidate genes. Prostaglandins Leukot. Essent. Fatty Acids (1999) 4(60):217-234.
   Google Scholar
• MCELROY SL, KOTWAL R, MALHOTRA S et al.: Are mood disorders and obesity related? A review for the mental health professional. J. Clin. Psychiatry (2004) 5(65):634-51, quiz.
   Google Scholar
• MCEWEN BS, MAGARINOS AM, REAGAN LP: Studies of hormone action in the hippocampal formation: possible relevance to depression and diabetes. J. Psychosom. Res. (2002) 4(53):883-890.
   Google Scholar
• MCEWEN BS: Mood disorders and allostatic load. Biol. Psychiatry (2003) 3(54):200-207.
   Google Scholar
• MCEWEN BS: Stress and hippocampal plasticity. Ann. Rev. Neurosci. (1999) 22:105-122.
   PubMed Web of Science ®Google Scholar
• REAGAN LP, GOROVITS N, HOSKIN EK et al.: Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats. Proc. Natl. Acad. Sci. USA (2001) 5(98):2820-2825.
   Google Scholar
• REAGAN LP, MAGARINOS AM, YEE DK et al.: Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Res. (2000) 1-2(862):292-300.
   Google Scholar
• REAGAN LP, MAGARINOS AM, MCEWEN BS: Neurological changes induced by stress in streptozotocin diabetic rats. Ann. N. Y. Acad. Sci. (1999) 893:126-137.
   PubMed Web of Science ®Google Scholar
• MACQUEEN GM, CAMPBELL S, MCEWEN BS et al.: Course of illness, hippocampal function, and hippocampal volume in major depression. Proc. Natl. Acad. Sci. USA (2003) 3(100):1387-1392.
   Google Scholar
• DEN HEIJER T, VERMEER SE, VAN DIJK EJ et al.: Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI. Diabetologia (2003) 12(46):1604-1610.
   Google Scholar
• MCINTYRE RS, SOCZYNSKA JK, KONARSKI JZ et al.: The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert. Opin. Drug Saf. (2006) 1(5):157-168.
   Google Scholar
• COOPER AJ, ASHCROFT G: Potentiation of insulin hypoglycaemia by M.A.O.I. antidepressant drugs. Lancet (1966) 7434(1):407-409.
   Google Scholar
• PARODI F: [On the antidiabetic effect of phenelzine]. Clin. Ter. (1967) 5(42):443-448.
   Google Scholar
• MCINTYRE RS, MANCINI DA, BASILE VS: Mechanisms of antipsychotic-induced weight gain. J. Clin. Psychiatry (2001) 62(Suppl. 23):23-29.
   PubMedGoogle Scholar
• NEWCOMER JW, HAUPT DW, FUCETOLA R et al.: Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia. Arch. Gen. Psychiatry (2002) 4(59):337-345.
   Google Scholar
• MCINTYRE RS: Antipsychotic drugs and diabetes. CMAJ (2003) 6(168):673.
   Google Scholar
• MCINTYRE RS: Psychotropic drugs and adverse events in the treatment of bipolar disorders revisited. J. Clin. Psychiatry (2002) 63 (Suppl. 3):15-20.
   PubMed Web of Science ®Google Scholar
• FEINSTEIN DL: Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease. Diabetes Technol. Ther. (2003) 1(5):67-73.
   Google Scholar
• FEINSTEIN D: Contrasting the neuroprotective and gliotoxic effects of PPARγ agonistis. Drug Discovery Today: Therapeutic Strategies (2004) 1(1):29-34.
   Google Scholar
• MATHEW SJ, KEEGAN K, SMITH L: Glutamate modulators as novel interventions for mood disorders. Rev. Bras. Psiquiatr. (2005) 3(27):243-248.
   Google Scholar
• GOULD E, TANAPAT P, MCEWEN BS et al.: Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc. Natl. Acad. Sci. USA (1998) 6(95):3168-3171.
   Google Scholar
• WOOD GE, YOUNG LT, REAGAN LP et al.: Stress-induced structural remodeling in hippocampus: prevention by lithium treatment. Proc. Natl. Acad. Sci. USA (2004) 11(101):3973-3978.
   Google Scholar
• GRAY NA, ZHOU R, DU J et al.: The use of mood stabilizers as plasticity enhancers in the treatment of neuropsychiatric disorders. J. Clin. Psychiatry (2003) 64 (Suppl. 5):3-17.
   PubMedGoogle Scholar
• MACQUEEN G, YOUNG T: Cognitive effects of atypical antipsychotics: focus on bipolar spectrum disorders. Bipolar. Disord. (2003) 5 (Suppl. 2):53-61.
   PubMedGoogle Scholar
• BEARDEN CE, HOFFMAN KM, CANNON TD: The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review. Bipolar. Disord. (2001) 3(3):106-150.
   PubMed Web of Science ®Google Scholar
• AUSTIN MP, MITCHELL P, GOODWIN GM: Cognitive deficits in depression: possible implications for functional neuropathology. Br. J. Psychiatry (2001) 178:200-206.
   PubMed Web of Science ®Google Scholar
• BOWIE CR, HARVEY PD: Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr. Clin. North Am. (2005) 3(28):613-633.
   Google Scholar
• THOMPSON JM, GALLAGHER P, HUGHES JH et al.: Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br. J Psychiatry (2005) 186:32-40.
   PubMed Web of Science ®Google Scholar
• MAGARINOS AM, MCEWEN BS: Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress. Proc. Natl. Acad. Sci. USA (2000) 20(97):11056-11061.
   Google Scholar
• MCEWEN BS, ALVES SE, BULLOCH K et al.: Ovarian steroids and the brain: implications for cognition and aging. Neurology (1997) 5 Suppl. 7(48):S8-S15.
   Google Scholar
• CRAFT S, WATSON GS: Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol. (2004) 3(3):169-178.
   PubMed Web of Science ®Google Scholar
• SHAPIRO E, BROWN SD, SALTIEL AR et al.: Short-term action of insulin on Aplysia neurons: generation of a possible novel modulator of ion channels. J. Neurobiol. (1991) 1(22):55-62.
   Google Scholar
• MASTERS BA, SHEMER J, JUDKINS JH et al.: Insulin receptors and insulin action in dissociated brain cells. Brain Res. (1987) 2(417):247-256.
   Google Scholar
• SHIBATA S, LIOU SY, UEKI S et al.: Inhibitory action of insulin on suprachiasmatic nucleus neurons in rat hypothalamic slice preparations. Physiol. Behav. (1986) 1(36):79-81.
   Google Scholar
• SKEBERDIS VA, LAN J, ZHENG X et al.: Insulin promotes rapid delivery of N-methyl-D- aspartate receptors to the cell surface by exocytosis. Proc. Natl. Acad. Sci. USA (2001) 6(98):3561-3566.
   Google Scholar
• KOPF SR, BARATTI CM: Effects of posttraining administration of insulin on retention of a habituation response in mice: participation of a central cholinergic mechanism. Neurobiol. Learn. Mem. (1999) 1(71):50-61.
   Google Scholar
• FIGLEWICZ DP, SZOT P, ISRAEL PA et al.: Insulin reduces norepinephrine transporter mRNA in vivo in rat locus coeruleus. Brain Res. (1993) 1(602):161-164.
   Web of Science ®Google Scholar
• GISPEN WH, BIESSELS GJ: Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. (2000) 11(23):542-549.
   Google Scholar
• ABBOTT MA, WELLS DG, FALLON JR: The insulin receptor tyrosine kinase substrate p58/53 and the insulin receptor are components of CNS synapses. J. Neurosci. (1999) 17(19):7300-7308.
   Google Scholar
• GREENWOOD CE, WINOCUR G: Glucose treatment reduces memory deficits in young adult rats fed high-fat diets. Neurobiol. Learn. Mem. (2001) 2(75):179-189.
   Google Scholar
• RICHARDSON JT: Cognitive function in diabetes mellitus. Neurosci. Biobehav. Rev. (1990) 4(14):385-388.
   Google Scholar
• WATSON GS, CHOLERTON BA, REGER MA et al.: Preserved cognition in patients with early Alzheimer’s disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am. J. Geriatr. Psychiatry (2005) 11(13):950-958.
   Google Scholar
• LUCHSINGER JA, TANG MX, SHEA S et al.: Hyperinsulinemia and risk of Alzheimer’s disease. Neurology (2004) 7(63):1187-1192.
   Google Scholar
• FROLICH L, BLUM-DEGEN D, BERNSTEIN HG et al.: Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease. J. Neural. Transm. (1998) 4-5(105):423-438.
   Google Scholar
• HONG M, LEE VM: Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J. Biol. Chem. (1997) 31(272):19547-19553.
   Google Scholar
• CRAFT S, ASTHANA S, SCHELLENBERG G et al.: Insulin metabolism in Alzheimer’s disease differs according to apolipoprotein E genotype and gender. Neuroendocrinology (1999) 2(70):146-152.
   Google Scholar
• BEERI MS, SILVERMAN JM, DAVIS KL et al.: Type 2 diabetes is negatively associated with Alzheimer’s disease neuropathology. J. Gerontol. A Biol. Sci. Med. Sci. (2005) 4(60):471-475.
   Google Scholar
• SCHUBERT M, GAUTAM D, SURJO D et al.: Role for neuronal insulin resistance in neurodegenerative diseases. Proc. Natl. Acad. Sci. USA (2004) 9(101):3100-3105.
   Google Scholar
• FISHER SJ, BRUNING JC, LANNON S et al.: Insulin signaling in the central nervous system is critical for the normal sympathoadrenal response to hypoglycemia. Diabetes (2005) 5(54):1447-1451.
   Google Scholar
• KITAMURA T, KAHN CR, ACCILI D: Insulin receptor knockout mice. Ann. Rev. Physiol. (2003) 65:313-332.
   PubMed Web of Science ®Google Scholar
• BRUNING JC, GAUTAM D, BURKS DJ et al.: Role of brain insulin receptor in control of body weight and reproduction. Science (2000) 5487(289):2122-2125.
   Google Scholar
• FOLLI F, GHIDELLA S, BONFANTI L et al.: The early intracellular signaling pathway for the insulin/insulin-like growth factor receptor family in the mammalian ‘central nervous system. Mol. Neurobiol. (1996) 2(13):155-183.
   Google Scholar
• ANTONETTI DA, ALGENSTAEDT P, KAHN CR: Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. Mol. Cell Biol. (1996) 5(16):2195-2203.
   Google Scholar
• FOLLI F, BONFANTI L, RENARD E et al.: Insulin receptor substrate-1 (IRS-1) distribution in the rat central nervous system. J. Neurosci. (1994) 11 Pt 1(14):6412-6422.
   Google Scholar
• KOKOEVA MV, YIN H, FLIER JS: Neurogenesis in the hypothalamus of adult mice: potential role in energy balance. Science (2005) 5748(310):679-683.
   Google Scholar
• CRAMOND WA: Lessons from the insulin story in psychiatry. Aust. N. Z. J. Psychiatry (1987) 3(21):320-326.
   Google Scholar
• OWENS DR, ZINMAN B, BOLLI G: Alternative routes of insulin delivery. Diabet. Med (2003) 11(20):886-898.
   Google Scholar
• BORN J, LANGE T, KERN W et al.: Sniffing neuropeptides: a transnasal approach to the human brain. Nat. Neurosci. (2002) 6(5):514-516.
   Google Scholar
• PONTIROLI AE: Peptide hormones: review of current and emerging uses by nasal delivery. Adv. Drug Deliv. Rev. (1998) 1-2(29):81-87.
   Google Scholar
• MERKUS P, GUCHELAAR HJ, BOSCH DA et al.: Direct access of drugs to the human brain after intranasal drug administration? Neurology (2003) 10(60):1669-1671.
   Google Scholar
• ILLUM L: Nasal drug delivery: new developments and strategies. Drug Discov. Today (2002) 23(7):1184-1189.
   Google Scholar
• THORNE RG, FREY WH: Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin. Pharmacokinet. (2001) 12(40):907-946.
   Google Scholar
• THORNE RG, PRONK GJ, PADMANABHAN V et al.: Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience (2004) 2(127):481-496.
   Google Scholar
• BENEDICT C, HALLSCHMID M, HATKE A et al.: Intranasal insulin improves memory in humans. Psychoneuroendocrinology (2004) 10(29):1326-1334.
   Google Scholar
• KERN W, BORN J, SCHREIBER H et al.: Central nervous system effects of intranasally administered insulin during euglycemia in men. Diabetes (1999) 3(48):557-563.
   Google Scholar
• HALLSCHMID M, BENEDICT C, SCHULTES B et al.: Intranasal insulin reduces body fat in men but not in women. Diabetes (2004) 11(53):3024-3029.
   Google Scholar
• FARR SA, POON HF, DOGRUKOL-AK D et al.: The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J. Neurochem. (2003) 5(84):1173-1183.
   Google Scholar
• ANDREASSEN OA, FERRANTE RJ, DEDEOGLU A et al.: Lipoic acid improves survival in transgenic mouse models of Huntington’s disease. Neuroreport (2001) 15(12):3371-3373.
   Google Scholar
• SHARMA M, GUPTA YK: Effect of alpha lipoic acid on intracerebroventricular streptozotocin model of cognitive impairment in rats. Eur. Neuropsychopharmacol. (2003) 4(13):241-247.
   Google Scholar
• ESTRADA DE, EWART HS, TSAKIRIDIS T et al.: Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes (1996) 12(45):1798-1804.
   Google Scholar
• ZIEGLER D, HANEFELD M, RUHNAU KJ et al.: Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care (1999) 8(22):1296-1301.
   Google Scholar
• FROLICH L, GOTZ ME, WEINMULLER M et al.: (r)-, but not (s)-alpha lipoic acid stimulates deficient brain pyruvate dehydrogenase complex in vascular dementia, but not in Alzheimer dementia. J. Neural Transm. (2004) 3(111):295-310.
   Google Scholar
• POON HF, FARR SA, THONGBOONKERD V et al.: Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem. Int. (2005) 2(46):159-168.
   Google Scholar
• MARRACCI GH, MCKEON GP, MARQUARDT WE et al.: Alpha lipoic acid inhibits human T-cell migration: implications for multiple sclerosis. J. Neurosci. Res. (2004) 3(78):362-370.
   Google Scholar
• MARRACCI GH, JONES RE, MCKEON GP et al.: Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis. J. Neuroimmunol. (2002) 1-2(131):104-114.
   Google Scholar
• SAUER J, TABET N, HOWARD R: Alpha lipoic acid for dementia. Cochrane. Database. Syst. Rev. (2004) 1:CD004244.
   PubMedGoogle Scholar
• HAGER K, MARAHRENS A, KENKLIES M et al.: Alpha-lipoic acid as a new treatment option for Azheimer type dementia. Arch. Gerontol. Geriatr. (2001) 3(32):275-282.
   Google Scholar
• A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders. Neurology (1998) 3(50):645-651.
   Google Scholar
• SALAZAR MR: Alpha lipoic acid: a novel treatment for depression. Med. Hypotheses (2000) 6(55):510-512.
   Google Scholar
• DOCHERTY JP, SACK DA, ROFFMAN M et al.: A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving. J. Psychiatr. Pract. (2005) 5(11):302-314.
   Google Scholar
• LIU PS, LIN MK: Biphasic effects of chromium compounds on catecholamine secretion from bovine adrenal medullary cells. Toxicology (1997) 1(117):45-53.
   Google Scholar
• FERNSTROM JD: The effect of nutritional factors on brain amino acid levels and monoamine synthesis. Fed. Proc. (1976) 5(35):1151-1156.
   Google Scholar
• ATTENBURROW MJ, ODONTIADIS J, MURRAY BJ et al.: Chromium treatment decreases the sensitivity of 5-HT2A receptors. Psychopharmacology (2002) 4(159):432-436.
   Google Scholar
• KHANAM R, PILLAI KK: Effect of chromium picolinate on modified forced swimming test in diabetic rats: involvement of serotonergic pathways and potassium channels. Basic Clin. Pharmacol. Toxicol. (2006) 2(98):155-159.
   Google Scholar
• DAVIDSON JR, ABRAHAM K, CONNOR KM et al.: Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biol. Psychiatry (2003) 3(53):261-264.
   Google Scholar
• MCLEOD MN, GAYNES BN, GOLDEN RN: Chromium potentiation of antidepressant pharmacotherapy for dysthymic disorder in 5 patients. J. Clin. Psychiatry (1999) 4(60):237-240.
   Google Scholar
• MCLEOD MN, GOLDEN RN: Chromium treatment of depression. Int. J. Neuropsychopharmacol. (2000) 4(3):311-314.
   Google Scholar
• LUNA-MEDINA R, CORTES-CANTELI M, ALONSO M et al.: Regulation of inflammatory response in neural cells in vitro by thiadiazolidinones derivatives through peroxisome proliferator-activated receptor gamma activation. J. Biol. Chem. (2005) 22(280):21453-21462.
   Google Scholar
• NATARAJAN C, BRIGHT JJ: Peroxisome proliferator-activated receptor-gamma agonists inhibit experimental allergic encephalomyelitis by blocking IL-12 production, IL-12 signaling and Th1 differentiation. Genes Immun. (2002) 2(3):59-70.
   Google Scholar
• HENEKA MT, KLOCKGETHER T, FEINSTEIN DL: Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo. J. Neurosci. (2000) 18(20):6862-6867.
   Google Scholar
• DELLO RC, GAVRILYUK V, WEINBERG G et al.: Peroxisome proliferator-activated receptor gamma thiazolidinedione agonists increase glucose metabolism in astrocytes. J. Biol. Chem. (2003) 8(278):5828-5836.
   Google Scholar
• REYNOLDS K, GOLDBERG RB: Thiazolidinediones: beyond glycemic control. Treat. Endocrinol. (2006) 1(5):25-36.
   Google Scholar
• RISNER ME, SAUNDERS AM, ALTMAN JF et al.: Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer’s disease. Pharmacogenomics. J. (2006) Epub ahead of print.
   PubMedGoogle Scholar
• RYAN CM, FREED MI, ROOD JA et al.: Improving metabolic control leads to better working memory in adults with Type 2 diabetes. Diabetes Care (2006) 2(29):345-351.
   Google Scholar
• KLOTZ L, SCHMIDT M, GIESE T et al.: Proinflammatory stimulation and pioglitazone treatment regulate peroxisome proliferator-activated receptor gamma levels in peripheral blood mononuclear cells from healthy controls and multiple sclerosis patients. J. Immunol. (2005) 8(175):4948-4955.
   Google Scholar
• VAN MONTFRANS JM, VAN HOOFF MH, HOMPES PG et al.: Treatment of hyperinsulinaemia in polycystic ovary syndrome? Hum. Reprod. (1998) 1(13):5-6.
   Google Scholar
• RASGON NL, CARTER MS, ELMAN S et al.: Common treatment of polycystic ovarian syndrome and major depressive disorder: case report and review. Curr. Drug Targets Immune. Endocr. Metabol. Disord. (2002) 2(1):97-102
   Google Scholar
• CHARNEY DS, BABICH KS: Foundation for the NIMH strategic plan for mood disorders research. Biol. Psychiatry (2002) 6(52):455-456.
   Google Scholar
• CHARBONNEL B, DORMANDY J, ERDMANN E et al.: The prospective pioglitazone clinical trial in macrovascular events (PROactive): can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients. Diabetes Care (2004) 7(27):1647-1653.
   Google Scholar
• BENEDICT C, DODT C, HALLSCHMID M et al.: Immediate but not long-term intranasal administration of insulin raises blood pressure in human beings. Metabolism (2005) 54(10):1356-1361.
   Google Scholar
• HARRISON LC, HONEYMAN MC, STEELE CE et al.: Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for Type 1 diabetes. Diabetes Care (2004) 27(10):2348-2355.
   Google Scholar
• KUPILA A, SIPILA J, KESKINEN P et al.: Intranasally administered insulin intended for prevention of Type 1 diabetes - a safety study in healthy adults. Diabetes Metab. Res. Rev. (2003) 19(5):415-420.
   Google Scholar
• QUINN JF, BUSSIERE JR, HAMMOND RS et al. Chronic dietary alpha-lipoic acid reduces deficits in hippocampal memory of aged Tg2576 mice. Neurobiol. Aging. (2006) [Epub ahead of print]
   Google Scholar
• PEDERSEN WA, FLYNN ER: Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease. Neurobiol. Dis. (2004) 17(3):500-506.
   Google Scholar
• LIU J, HEAD E, GHARIB AM et al.: Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha -lipoic acid. Proc. Natl Acad. Sci. USA (2002) 99(4):2356-2361.
   Google Scholar
• STORER PD, XU J, CHAVIS J et al.: Peroxisome proliferator-activated receptor-gamma agonists inhibit the activation of microglia and astrocytes: implications for multiple sclerosis. J. Neuroimmunol. (2005) 161(1-2):113-122.
   Google Scholar
• MORINI M, ROCCATAGLIATA L, DELL'EVA R et al.: Alpha-lipoic acid is effective in prevention and treatment of experimental autoimmune encephalomyelitis. J. Neuroimmunol. (2004) 148(1-2):146-145.
   Google Scholar
• FEINSTEIN DL, GALEA E, GAVRILYUK V et al.: Peroxisome proliferator-activated receptor-gamma agonists prevent experimental autoimmune encephalomyelitis. Ann. Neurol. (2002) 51(6):694-702.
   Google Scholar
• STOLL S, HARTMANN H, COHEN SA et al.: The potent free radical scavenger alpha-lipoic acid improves memory in aged mice: putative relationship to NMDA receptor deficits. Pharmacol. Biochem. Behav. (1993) 46(4):799-805.
   Google Scholar
• KHANAM R, PILLAI KK: Effect of chromium picolinate on modified forced swimming test in diabetic rats: involvement of serotonergic pathways and potassium channels. Basic Clin. Pharmacol. Toxicol. (2006) 98(2):155-159.
   Google Scholar
• BIESSELS GJ, SMALE S, DUIS SE et al.: The effect of gamma-linolenic acid-alpha-lipoic acid on functional deficits in the peripheral and central nervous system of streptozotocin-diabetic rats. J. Neurol. Sci. (2001) 182(2):99-106.
   Google Scholar
• PERSHADSINGH HA, HENEKA MT, SAINI R et al.: Effect of pioglitazone treatment in a patient with secondary multiple sclerosis. J. Neuroinflammation (2004) 1(1):3.
   Google Scholar
• SLOAN RW, KREIDER RM, LUDERER J: The effect of chlorpropamide hyponatremia on mental status in a nursing home population. J. Fam. Pract. (1983) 16(5):937-942.
   Google Scholar